8-K
filed February 7, 2023, 6:59 PM ET
ticker DOC
CIK 0000765880
earnings
confidence high
sentiment neutral
materiality 0.70
Healthpeak Q4 FFO as Adjusted $0.44, Same-Store NOI +6.6%; Plans UPREIT Reorg
HEALTHPEAK PROPERTIES, INC.
2022-FY EPS reported
$0.92
revenue$2,061,178,000
- Q4 net income $0.01/diluted share, FFO as Adjusted $0.44/diluted share; FY 2022 FFO as Adjusted $1.74/share.
- Total Same-Store Portfolio Cash NOI +6.6% in Q4, +5.0% for FY; Life Science +5.1%, MOB +4.0%.
- $900M life science development pipeline 78% pre-leased; acquired 2.2 acres in Cambridge for $27M.
- Issued $400M 5.25% 10-yr senior notes; net debt to adjusted EBITDAre 5.3x.
- Plans UPREIT reorganization in Q1 2023; declared $0.30/share dividend payable Feb 23.
Key facts
Extracted from this filing and checked against the source text.
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
HEALTHPEAK PROPERTIES, INC. reported Three Months Ended December 31, 2022 results: net income $6,388 (in thousands), EPS $0.01 per share.
- Period
- Three Months Ended December 31, 2022
- Net income
- $6,388 (in thousands)
- EPS
- $0.01 per share
- Result
- reported results
Exact text from the filing
Three Months Ended December 31, 2022 Three Months Ended December 31, 2021 (in thousands, except per share amounts) Amount Per Share Amount Per Share Net income, diluted $ 6,388 $ 0.01 $ 28,493 $ 0.05
View on SEC.gov
Earnings Releases
SEC 8-K Item 2.02
confidence 0.9
HEALTHPEAK PROPERTIES, INC. reported Year Ended December 31, 2022 results: net income $497,792 (in thousands), EPS $0.92 per share.
- Period
- Year Ended December 31, 2022
- Net income
- $497,792 (in thousands)
- EPS
- $0.92 per share
- Result
- reported results
Exact text from the filing
Year Ended December 31, 2022 Year Ended December 31, 2021 (in thousands, except per share amounts) Amount Per Share Amount Per Share Net income, diluted $ 497,792 $ 0.92 $ 502,271 $ 0.93
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.